AI Drug Discovery: Who Owns the IP Rights?

Send us Fan Mail Episode Summary When an AI model designs a novel therapeutic molecule or predicts an enzyme structure, who legally owns the resulting intellectual property? In this episode of Darshan Talks / KF Deep Dive, host Darshan Kulkarni turns the microphone over to Stu Angus (Founder of Scriptome.AI) for a reverse interview exploring the legal, regulatory, and philosophical chasms surrounding AI-generated pharma assets. Together, they confront the core requirement of "human ingenuity"...